BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17552551)

  • 21. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.
    Whiteaker JR; Zhang H; Zhao L; Wang P; Kelly-Spratt KS; Ivey RG; Piening BD; Feng LC; Kasarda E; Gurley KE; Eng JK; Chodosh LA; Kemp CJ; McIntosh MW; Paulovich AG
    J Proteome Res; 2007 Oct; 6(10):3962-75. PubMed ID: 17711321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of immature adipogenic status and identification of prognostic biomarkers in myxoid liposarcoma using tissue microarrays.
    Cheng H; Dodge J; Mehl E; Liu S; Poulin N; van de Rijn M; Nielsen TO
    Hum Pathol; 2009 Sep; 40(9):1244-51. PubMed ID: 19368956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Artificial neural networks and decision tree model analysis of liver cancer proteomes.
    Luk JM; Lam BY; Lee NP; Ho DW; Sham PC; Chen L; Peng J; Leng X; Day PJ; Fan ST
    Biochem Biophys Res Commun; 2007 Sep; 361(1):68-73. PubMed ID: 17644064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies.
    Kulasingam V; Diamandis EP
    Nat Clin Pract Oncol; 2008 Oct; 5(10):588-99. PubMed ID: 18695711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic identification of salivary biomarkers of type-2 diabetes.
    Rao PV; Reddy AP; Lu X; Dasari S; Krishnaprasad A; Biggs E; Roberts CT; Nagalla SR
    J Proteome Res; 2009 Jan; 8(1):239-45. PubMed ID: 19118452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. iTRAQ-multidimensional liquid chromatography and tandem mass spectrometry-based identification of potential biomarkers of oral epithelial dysplasia and novel networks between inflammation and premalignancy.
    Ralhan R; Desouza LV; Matta A; Tripathi SC; Ghanny S; Dattagupta S; Thakar A; Chauhan SS; Siu KW
    J Proteome Res; 2009 Jan; 8(1):300-9. PubMed ID: 19072117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Entering a new era of rational biomarker discovery for early detection of melanoma metastases: secretome analysis of associated stroma cells.
    Paulitschke V; Kunstfeld R; Mohr T; Slany A; Micksche M; Drach J; Zielinski C; Pehamberger H; Gerner C
    J Proteome Res; 2009 May; 8(5):2501-10. PubMed ID: 19222175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology.
    Petri AL; Simonsen AH; Yip TT; Hogdall E; Fung ET; Lundvall L; Hogdall C
    Acta Obstet Gynecol Scand; 2009; 88(1):18-26. PubMed ID: 19023702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Proteomics and breast cancer: a search for novel diagnostic and theragnostic biomarkers].
    Gilabert M; Audebert S; Viens P; Borg JP; Bertucci F; Gonçalves A
    Bull Cancer; 2010 Mar; 97(3):321-39. PubMed ID: 20202919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Requirements for the valid quantification of immunostains on tissue microarray materials using image analysis.
    Decaestecker C; Lopez XM; D'Haene N; Roland I; Guendouz S; Duponchelle C; Berton A; Debeir O; Salmon I
    Proteomics; 2009 Oct; 9(19):4478-94. PubMed ID: 19670370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery and validation of protein abundance differences between follicular thyroid neoplasms.
    Netea-Maier RT; Hunsucker SW; Hoevenaars BM; Helmke SM; Slootweg PJ; Hermus AR; Haugen BR; Duncan MW
    Cancer Res; 2008 Mar; 68(5):1572-80. PubMed ID: 18316623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry.
    DeSouza L; Diehl G; Rodrigues MJ; Guo J; Romaschin AD; Colgan TJ; Siu KW
    J Proteome Res; 2005; 4(2):377-86. PubMed ID: 15822913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue microarray validation: a methodologic study with special reference to lung cancer.
    Karlsson C; Bodin L; Piehl-Aulin K; Karlsson MG
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2014-21. PubMed ID: 19531681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of proteomics in ovarian cancer: which sample should be used?
    Cadron I; Van Gorp T; Timmerman D; Amant F; Waelkens E; Vergote I
    Gynecol Oncol; 2009 Dec; 115(3):497-503. PubMed ID: 19811810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A proteomics study on human breast cancer cell lines by fluorogenic derivatization-liquid chromatography/tandem mass spectrometry.
    Imai K; Ichibangase T; Saitoh R; Hoshikawa Y
    Biomed Chromatogr; 2008 Nov; 22(11):1304-14. PubMed ID: 18821527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry.
    Ralhan R; Desouza LV; Matta A; Tripathi SC; Ghanny S; Datta Gupta S; Bahadur S; Siu KW
    Mol Cell Proteomics; 2008 Jun; 7(6):1162-73. PubMed ID: 18339795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serum diagnosis of head and neck squamous cell carcinoma using surface-enhanced desorption ionization mass spectrometry and artificial neural network analyses].
    Cao SM; Guo X; Chen FJ; Yang AK; Chen WK; Li NW
    Ai Zheng; 2007 Jul; 26(7):767-70. PubMed ID: 17626756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of high-throughput mass spectrometry-based approaches for cancer biomarker discovery and implementation.
    Hood BL; Stewart NA; Conrads TP
    Clin Lab Med; 2009 Mar; 29(1):115-38. PubMed ID: 19389555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.